Abstract: A Fluid Flow Control System (FFCS) door assembly includes a continuous belt and a plurality of rollers. The plurality of rollers support the continuous belt and define a first segment, a second segment, a third segment, and a fourth segment. The continuous belt includes a plurality of openings that selectively allow fluid flow to pass through the first segment, the second segment, the third segment, and the fourth segment when two openings of the plurality of openings align with the first segment, the second segment, the third segment, or the fourth segment.

Abstract: The treatment of human subjects suffering from COVID-19 comprises the step of administering to the human subjects a medicament selected from the group consisting of 1,3-bis(7-methoxy-4,9-dihydro-3H-pyrido[3,4-b]indol-1-yl)propane, and/or the isomers, tautomers, enantiomers, esters, derivatives, metal complexes, prodrugs, solvates, metabolites, and pharmaceutically acceptable salts thereof. The medicament may also be contacted with SARS-CoV-2 virus for inhibition of the virus.

Abstract: Multiple active component therapeutic formulations are described comprising at least two active agents selected from the group consisting of an isovanillin component, a harmine component, and a curcumin component, stabilized in a self-supporting lipid crystalline formulation for topical application. The formulation maintains the active agents in a stable form during storage and will melt at body temperature when applied to the skin, wherein the lipid crystals melt into a liquid crystalline structure thereby releasing the active agents to the applied area of the skin or tissue to render their therapeutic effect.

Abstract: Topical medicaments for the treatment of mammalian skin are provided, which include an actives fraction and a carrier fraction; the actives fraction comprises individual amounts of turmeric, Peganum harmala, and Arum palaestinum. In other embodiments, the actives fraction includes additional ingredients, including Vitamin C, ?-sitosterol, and vanillin compound(s). The medicaments are useful in the treatment of a wide variety of conditions.

Abstract: The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a multiple-component antiviral formulation comprising a curcumin component, harmine component, and isovanillin component, and/or variants thereof. The formulation may also be used to inhibit SARS-CoV-2 virus in cell-based assays or in the manufacture of antiviral medicaments.

Abstract: The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a formulation comprising turmeric, Peganum harmala, and Arum palaestinum, and/or variants thereof. Methods of inhibiting SARS-CoV-2 viral replication are also described.

Abstract: The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a formulation comprising Arum spp., particularly Arum palaestinum. Methods of inhibiting SARS-CoV-2 viral replication are also disclosed comprising contacting the virus with an Arum formulation.

Abstract: Novel medicaments for the treatment of actinic keratoses are provided, along with methods of treatment. The medicaments include respective quantities of curcumin, harmine, and isovanillin, which can be used alone or in combination with fluorouracil. In the latter cases, the three-component compositions provide a synergistic or adjuvant effect with fluorouracil.

Abstract: The treatment of human subjects suffering from COVID-19 comprises the step of administering to the human subjects a medicament selected from the group consisting of 1,3-bis(7-methoxy-4,9-dihydro-3H-pyrido[3,4-b]indol-1-yl)propane, and/or the isomers, tautomers, enantiomers, esters, derivatives, metal complexes, prodrugs, solvates, metabolites, and pharmaceutically acceptable salts thereof. The medicament may also be contacted with SARS-CoV-2 virus for inhibition of the virus.

Abstract: A Fluid Flow Control System (FFCS) door assembly includes a continuous belt and a plurality of rollers. The plurality of rollers support the continuous belt and define a first segment, a second segment, a third segment, and a fourth segment. The continuous belt includes a plurality of openings that selectively allow fluid flow to pass through the first segment, the second segment, the third segment, and the fourth segment when two openings of the plurality of openings align with the first segment, the second segment, the third segment, or the fourth segment.

Abstract: Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.

Abstract: Combination dosage forms of anti-cancer products include components a) and b), where component a) comprises individual amounts of curcumin, harmine, isovanillin, and component b) comprises an agent selected from the group consisting of EGFR inhibitors, CDK 4/6 inhibitors, 5-fluorouracil, checkpoint inhibitors, anti-metabolites, prodrugs thereof, and mixtures thereof. The products may be administered to mammalian subjects suffering from a variety of cancers, to provide a synergistic therapeutic effect.

Abstract: A fastening system includes a first connector and a second connector. The first connector has a protrusion, a first clip, and a first catch. The first clip and the first catch are offset from the protrusion. The second connector defines a slot, has a second clip, and has a second catch. The second clip and the second catch are offset from the slot. The slot is configured to receive the protrusion upon engagement between the first connector and the second connector. The first clip is biased into engagement with the second catch and the second clip is biased into engagement with the first catch upon engagement between the first connector and the second connector to secure the first connector to the second connector.

Abstract: A heating, ventilation, and air conditioning (HVAC) system including a plurality of airflow control doors. A plurality of door gears are in cooperation with the plurality of airflow control doors such that rotation of each one of the plurality of door gears actuates a different one of the plurality of airflow control doors to control airflow through the HVAC system. A selector gear is moveable to individually rotate each one of the plurality of door gears to selectively actuate different ones of the plurality of airflow control doors. A power gear rotates the selector gear.

Abstract: A heating, ventilation, and air conditioning (HVAC) system including an HVAC assembly, a set of pins, mode doors, a mode plate, an actuator, and an HVAC control module. The mode doors control airflow from the HVAC assembly. A position of each mode door is controlled by a corresponding pin of the set of pins. The mode plate includes (i) a set of grooves, (ii) a first adjustment path and (iii) a second adjustment path. The first adjustment path causes a first pin of the set of pins to move toward a center. The second adjustment path causes the first pin to move away from the center of the mode plate. An HVAC module selectively actuates the actuator to causes the mode plate to rotate in at least one of a passive direction and the active direction in response to receiving a mode request.

Abstract: Topical medicaments for the treatment of mammalian skin are provided, which include an actives fraction and a carrier fraction; the actives fraction comprises individual amounts of turmeric, Peganum harmala, and Arum palaestinum. In other embodiments, the actives fraction includes additional ingredients, including Vitamin C, ?-sitosterol, and vanillin compound(s). The medicaments are useful in the treatment of a wide variety of conditions.

Abstract: A heating, ventilation, and air conditioning (HVAC) system including a plurality of airflow control doors. A plurality of door gears are in cooperation with the plurality of airflow control doors such that rotation of each one of the plurality of door gears actuates a different one of the plurality of airflow control doors to control airflow through the HVAC system. A selector gear is moveable to individually rotate each one of the plurality of door gears to selectively actuate different ones of the plurality of airflow control doors. A power gear rotates the selector gear.

Abstract: A heating, ventilation, and air conditioning (HVAC) system including an HVAC assembly, a set of pins, mode doors, a mode plate, an actuator, and an HVAC control module. The mode doors control airflow from the HVAC assembly. A position of each mode door is controlled by a corresponding pin of the set of pins. The mode plate includes (i) a set of grooves, (ii) a first adjustment path and (iii) a second adjustment path. The first adjustment path causes a first pin of the set of pins to move toward a center. The second adjustment path causes the first pin to move away from the center of the mode plate. An HVAC module selectively actuates the actuator to causes the mode plate to rotate in at least one of a passive direction and the active direction in response to receiving a mode request.

Abstract: Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.

Abstract: The present invention provides an organic chip carrier particularly useful with flip chips. The chip carrier comprises an organic dielectric layer, a first layer of circuitry disposed on the dielectric layer, an organic conformational coating disposed over the first layer of dielectric and the first layer of circuitry, and a layer of fine line circuitry. The fine line circuitry has a line width of about 2.0 mil or less, preferably about 1.0 mil or less, and more preferably about 0.7 mil, and a space between lines of about 1.5 mil or less, preferably about 1.1 mil or less. Preferably the dielectric layer is free of woven fiber glass. The conformational coating preferably has a dielectric constant of about 1.5 to about 3.5, and a percent planarization of greater than about 30%. The invention also relates to methods of making the dielectric coated chip carrier.